Taysha Gene Therapies, Inc. ($TSHA)
Filing Information
| Accession Number | 0001665124-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 14, 2026 |
| Document Date | Jan 12, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
1,301,000
Total Value
$1,171,440.30
P&L
+inf% (+$3,084,400.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 12, 2026 | Exercise/Conversion | 111,324 | $0.70 | $77,804.34 | 1,117,763 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Exercise/Conversion | 88,676 | $1.71 | $151,635.96 | 1,206,439 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 200,000 | $4.71 | $942,000.00 | 1,006,439 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Grant/Award | 427,000 | $0.00 | $0.00 | 1,433,439 | Direct | โ | View Details | |
Director | Employee Stock Option (right to buy) | Derivative | Jan 12, 2026 | Exercise/Conversion | 111,324 | $0.00 | $0.00 | 111,359 | Direct | โ | View Details | |
Director | Employee Stock Option (right to buy) | Derivative | Jan 12, 2026 | Exercise/Conversion | 88,676 | $0.00 | $0.00 | 474,941 | Direct | โ | View Details | |
Director | Employee Stock Option (right to buy) | Derivative | Jan 12, 2026 | Grant/Award | 274,000 | $0.00 | $0.00 | 274,000 | Direct | โ | View Details |